ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    A Retrospective Analysis of the Safety and Efficacy of Apixaban After Lung Transplant

    T. Sam1, K. Reininger2, R. Patel1, C. Naik1, K. Ausloos1, R. Rosenblatt1, T. Grazia1, I. Lam3

    1Transplant, Baylor University Medical Center, Dallas, TX, 2Transplant, Hennepin County Medical Center, Minneapolis, MN, 3Transplant, Sharp Memorial Hospital, San Diego, CA

    *Purpose: Atrial arrhythmias and venous thromboembolism (VTE) are common after lung transplant. While direct acting oral anticoagulants (DOACs) have become anticoagulants of choice in atrial…
  • 2021 American Transplant Congress

    Combined Liver and Lung Transplantation with Extended Normothermic Liver Preservation Using Transmedics Organ Care System (OCS)TM Liver: A Single Center Experience

    J. Konel1, M. Shamaa2, O. Shamaa2, A. Elsabbagh2, T. Kitajima2, T. Ivanics2, K. Delvecchio2, A. Mohamed2, S. Yeddula2, K. Collins2, A. Yoshida2, M. Abouljoud2, S. Nagai2, M. Rizzari2

    1Wayne State University School of Medicine, Detroit, MI, 2Henry Ford Transplant Institute, Detroit, MI

    *Purpose: Combined liver-lung transplantation (CLLT) is indicated in patients who cannot survive single-organ transplantation alone. Ex-situ normothermic machine perfusion (NMP) has been used to increase…
  • 2021 American Transplant Congress

    Gray on the Border: A Closer Look at the Gap in Access to Kidney Transplantation for Hispanic Americans

    A. Padilla, M. Mujtaba, R. Samper-Ternent, S. Al Snih, N. Perez, J. Fair, R. Kulkarni, E. Polychronopoulou, M. Kueht

    University of Texas Medical Branch, Galveston, TX

    *Purpose: Hispanic Americans have disproportionately reduced access to kidney transplantation that is significantly affected by longstanding cultural and geographical disparities. These disparities are multifactorial and…
  • 2021 American Transplant Congress

    Genetic versus Self-reported African Ancestry and Kidney Allograft Outcome: Analysis of Two Large Multiethnic Urban Transplant Cohorts

    F. Zanoni1, D. Neugut1, S. Mohan1, A. Gharavi1, B. Keating2, K. Kiryluk1

    1Department of Medicine, Division of Nephrology, Columbia University, New York, NY, 2Department of Surgery, Division of Transplantation, University of Pennsylvania, Philadelphia, PA

    *Purpose: African-American (AA) kidney transplant recipients (KTx) have higher risk of rejection and failure. However, it is unknown to what extent the inferior outcomes in…
  • 2021 American Transplant Congress

    One-Year Monitoring of Changes to Kidney-Pancreas Waiting Time Criteria: An OPTN Analysis

    R. C. Forbes1, B. Plucinski2, J. White2, N. T. Kyaw2, R. Kandaswamy3, S. V. Niederhaus4

    1Surgery, Vanderbilt University, Nashville, TN, 2UNOS, Richmond, VA, 3Surgery, University of Minnesota, Minneapolis, MN, 4Surgery, University of Maryland, Baltimore, MD

    *Purpose: In 2018, the OPTN board approved changes to kidney-pancreas (KP) waiting time criteria. KP candidates accrued waiting time if they were (1) on insulin…
  • 2021 American Transplant Congress

    COVID-19 Presentation and Severity Within One Year of Pancreas and Kidney Transplantation

    H. Sarumi, J. Fisher, B. Johnson, T. Pruett

    University of Minnesota, Minneapolis, MN

    *Purpose: The current pandemic has created uncertainty of induction regimen impact upon severity of COVID-19 disease. Our experience with COVID-19 infection was reviewed to stratify…
  • 2021 American Transplant Congress

    Letermovir Prophylaxis in Solid Organ Transplant – CMV Breakthrough and Tacrolimus Drug Interaction

    R. Winstead1, D. Kumar1, A. Brown1, I. Yakubu1, C. Song1, L. Thacker2, G. Gupta1

    1Virginia Commonwealth University Health, Richmond, VA, 2Virginia Commonwealth University, Richmond, VA

    *Purpose: Valganciclovir is the preferred drug for cytomegalovirus (CMV) prophylaxis in solid organ transplantation. A limitation to its use is profound myelosuppression. Letermovir is a…
  • 2021 American Transplant Congress

    Investigating Physician Outlook Regarding Living Donation Prior to Planned Withdrawal of Care

    S. Rath1, L. Washburn2, S. Creden1, M. Goss3, A. Rana1, J. Goss1, N. T. Galvan1

    1Baylor College of Medicine, Houston, TX, 2University of Pittsburgh Medical Center, Pittsburgh, PA, 3McGovern Medical School, Houston, TX

    *Purpose: The aim of this study is to assess the attitudes of physicians, physician assistants, and nurse practitioners in transplant and critical care regarding Living…
  • 2021 American Transplant Congress

    Short Term Outcomes in Previously Covid Positive Kidney Transplant Recipients in Pre-vaccine Era

    R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel

    Henry Ford Transplant Institute, Detroit, MI

    *Purpose: To study clinical characteristics and short-term outcomes in kidney transplant recipients who were previously infected with SARS-CoV-2*Methods: In this retrospective, single-center case-series, we identified…
  • 2021 American Transplant Congress

    Characterisation of Distinct Graft Infiltrates Following Cellular Therapy in Kidney Transplant Recipients

    M. O. Brook1, P. N. Harden2, I. Roberts2, W. R. Mulley3, J. Hester1, M. E. Reinders4, F. Issa1

    1Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom, 2Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom, 3Department of Nephrology, Monash Medical Centre, Melbourne, Australia, 4Division of Nephrology and Transplant Center, Leiden University Medical Center, Leiden, Netherlands

    *Purpose: Cellular therapy is an emerging treatment in the field of clinical transplantation with the potential to improve both short and long-term transplant outcomes. We…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 139
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences